WuXi AppTec
Company Snapshot
Company Overview
WuXi AppTec was founded in 2000 in WuXi, Jiangsu, and operates in Shanghai. It is a global pharmaceutical, biopharmaceutical, and medical device company that delivers a broad portfolio of R&D and manufacturing services that support over 5,900 collaborative partners around the globe to advance discoveries and provide groundbreaking therapies in patients. The company operates across Asia, Europe, and North America. The business model is end-to-end services, including chemistry drug CRDMO (Contract Research, Development, and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, and cell and gene therapies CTDMO (Contract Testing, Development, and Manufacturing Organization), helping customers to improve the productivity of advancing healthcare products through cost-effective and efficient solutions.
Financial Highlights (FY 2023)
This information is available for BCC Research members only.
Company's Business Segments
- WuXi Chemistry : It deals with the chemistry business of the company.
- WuXi Testing : It deals with the testing business of the company.
- WuXi Biology : It deals with the biology business of the company.
- WuXi ATU : It deals with the advanced therapies CTDMO business of the company.
- WuXi DDSU : It deals with the domestic new drug discovery service unit of the company.
Applications/End User Industries
- Pharmaceutical
- Life Sciences
- Healthcare
